Although c-Myc expression is tightly regulated in normal cells, deregulation of c-Myc occurs in up to 70% of human cancers due to multiple mechanisms, including the gain in genetic copy number (chromosomal amplification or translocation), activation of superenhancers, aberrant upstream signaling, and altered protein stability [13]. Here, MYC is linked to cancer.